Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 2724-2728, May 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. H.
Right arrow Articles by Blick, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. H.
Right arrow Articles by Blick, M.

Frequent Loss of Heterozygosity on Chromosomes 6q, 11, and 17 in Human Ovarian Carcinomas1

Je H. Lee, John J. Kavanagh, David M. Wildrick, J. Taylor Wharton and Mark Blick2

Department of Medical Oncology [J. H. L., J. J. K., D. M. W.], Department of Gynecology [J. T. W.], and Department of Clinical Immunology and Biological Therapy [M. B.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Recently, tumor-specific allele loss has been shown to be an important characteristic of some tumors. When such loss includes one or more growth-regulatory genes, it may allow the expression of tumorigenicity. Using Southern blots, we analyzed normal and tumor DNA samples from 19 ovarian cancer patients, using a series of polymorphic DNA probes that map to a variety of chromosomal loci. Of 14 informative cases, tumor-specific allelic loss was observed in nine (64%) at the estrogen receptor (ESR) gene locus on chromosome 6q. On chromosome 17p at the D17S28 and D17S30 loci, allelic losses were also detected in 6 of 8 (75%) and 9 of 14 (64%) cases, respectively. Allelic loss at the HRAS1 gene locus on chromosome 11p occurred in 5 of 11 (46%) informative cases. The relatively high incidence of these allelic losses observed on chromosome 6q represents the first implication by molecular genetic analysis of this chromosomal region in a human malignancy, and it thus appears to be a genetic change specific to ovarian carcinoma. DNA sequence losses on 11p and 17p, also reported for other cancers, may reflect the presence of tumor- or growth-suppressor genes on these chromosomes that are important in the genesis of many tumor types, including ovarian malignancies.

1 Supported by an Institutional Research Grant, The University of Texas M. D. Anderson Cancer Center, Houston, TX, and the Bessie Frisch Memorial Fund.

2 To whom requests for reprints should be addressed, at Molecular Analysis Incorporated, 8000 El Rio, Houston, TX 77054.

Received 6/ 9/89. Revised 12/21/89.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Takahashi, Y. Miyoshi, C. Takahata, N. Irahara, T. Taguchi, Y. Tamaki, and S. Noguchi
Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers
Clin. Cancer Res., February 15, 2005; 11(4): 1380 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. W. Wang, D. A. Bell, R. S. Berkowitz, and S. C. Mok
Whole Genome Amplification and High-Throughput Allelotyping Identified Five Distinct Deletion Regions on Chromosomes 5 and 6 in Microdissected Early-Stage Ovarian Tumors
Cancer Res., May 1, 2001; 61(10): 4169 - 4174.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
R. L. Baldwin, E. Nemeth, H. Tran, H. Shvartsman, I. Cass, S. Narod, and B. Y. Karlan
BRCA1 Promoter Region Hypermethylation in Ovarian Carcinoma: A Population-based Study
Cancer Res., October 1, 2000; 60(19): 5329 - 5333.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. Schneider, S. Borgnat, H. Lang, O. Régine, V. Lindner, M. Kassem, C. Saussine, P. Oudet, D. Jacqmin, and M. P. Gaub
Evaluation of Microsatellite Analysis in Urine Sediment for Diagnosis of Bladder Cancer
Cancer Res., August 1, 2000; 60(16): 4617 - 4622.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
N. Mori, R. Morosetti, E. Hoflehner, M. Lubbert, H. Mizoguchi, and H. P. Koeffler
Allelic Loss in the Progression of Myelodysplastic Syndrome
Cancer Res., June 1, 2000; 60(11): 3039 - 3042.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-P. Kim, J.-H. Roe, P. B. Chock, and M. B. Yim
Transcriptional Activation of the Human Manganese Superoxide Dismutase Gene Mediated by Tetradecanoylphorbol Acetate
J. Biol. Chem., December 24, 1999; 274(52): 37455 - 37460.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Hatta, Y. Yamada, M. Tomonaga, I. Miyoshi, J. W. Said, and H. P. Koeffler
Detailed Deletion Mapping of the Long Arm of Chromosome 6 in Adult T-Cell Leukemia
Blood, January 15, 1999; 93(2): 613 - 616.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Hatta, Y. Yamada, M. Tomonaga, J. W. Said, I. Miyosi, and H. P. Koeffler
Allelotype Analysis of Adult T-Cell Leukemia
Blood, September 15, 1998; 92(6): 2113 - 2117.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.